214 related articles for article (PubMed ID: 36341839)
21. Statin Use Mitigate the Benefit of Omega-3 Fatty Acids Supplementation-A Meta-Regression of Randomized Trials.
Sethi A; Bajaj A; Khosla S; Arora RR
Am J Ther; 2016; 23(3):e737-48. PubMed ID: 25036814
[TBL] [Abstract][Full Text] [Related]
22. Omega-3 polyunsaturated fatty acids and cardiovascular diseases.
Lavie CJ; Milani RV; Mehra MR; Ventura HO
J Am Coll Cardiol; 2009 Aug; 54(7):585-94. PubMed ID: 19660687
[TBL] [Abstract][Full Text] [Related]
23. Comparing the Effects of Docosahexaenoic and Eicosapentaenoic Acids on Inflammation Markers Using Pairwise and Network Meta-Analyses of Randomized Controlled Trials.
Vors C; Allaire J; Mejia SB; Khan TA; Sievenpiper JL; Lamarche B
Adv Nutr; 2021 Feb; 12(1):128-140. PubMed ID: 32790827
[TBL] [Abstract][Full Text] [Related]
24. Role of omega-3 fatty acids in the treatment of depressive disorders: a comprehensive meta-analysis of randomized clinical trials.
Grosso G; Pajak A; Marventano S; Castellano S; Galvano F; Bucolo C; Drago F; Caraci F
PLoS One; 2014; 9(5):e96905. PubMed ID: 24805797
[TBL] [Abstract][Full Text] [Related]
25. Omega-3 dietary supplements and the risk of cardiovascular events: a systematic review.
Marik PE; Varon J
Clin Cardiol; 2009 Jul; 32(7):365-72. PubMed ID: 19609891
[TBL] [Abstract][Full Text] [Related]
26. Omega-3 Polyunsaturated Fatty Acids for Core Symptoms of Attention-Deficit/Hyperactivity Disorder: A Meta-Analysis of Randomized Controlled Trials.
Liu TH; Wu JY; Huang PY; Lai CC; Chang JP; Lin CH; Su KP
J Clin Psychiatry; 2023 Aug; 84(5):. PubMed ID: 37656283
[No Abstract] [Full Text] [Related]
27. Disentangling the Molecular Mechanisms of the Antidepressant Activity of Omega-3 Polyunsaturated Fatty Acid: A Comprehensive Review of the Literature.
Kalkman HO; Hersberger M; Walitza S; Berger GE
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33922396
[TBL] [Abstract][Full Text] [Related]
28. Omega-3 polyunsaturated fatty acids in cardiovascular diseases comorbid major depressive disorder - Results from a randomized controlled trial.
Chang JP; Chang SS; Yang HT; Chen HT; Chien YC; Yang B; Su H; Su KP
Brain Behav Immun; 2020 Mar; 85():14-20. PubMed ID: 30902738
[TBL] [Abstract][Full Text] [Related]
29. Safety of Supplementation of Omega-3 Polyunsaturated Fatty Acids: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Chang JP; Tseng PT; Zeng BS; Chang CH; Su H; Chou PH; Su KP
Adv Nutr; 2023 Nov; 14(6):1326-1336. PubMed ID: 37567449
[TBL] [Abstract][Full Text] [Related]
30. Omega-3 and omega-6 polyunsaturated fatty acids for dry eye disease.
Downie LE; Ng SM; Lindsley KB; Akpek EK
Cochrane Database Syst Rev; 2019 Dec; 12(12):CD011016. PubMed ID: 31847055
[TBL] [Abstract][Full Text] [Related]
31. A biological rationale for the disparate effects of omega-3 fatty acids on cardiovascular disease outcomes.
Sherratt SCR; Libby P; Bhatt DL; Mason RP
Prostaglandins Leukot Essent Fatty Acids; 2022 Jul; 182():102450. PubMed ID: 35690002
[TBL] [Abstract][Full Text] [Related]
32. n-3 fatty acids and cardiovascular events after myocardial infarction.
Kromhout D; Giltay EJ; Geleijnse JM;
N Engl J Med; 2010 Nov; 363(21):2015-26. PubMed ID: 20929341
[TBL] [Abstract][Full Text] [Related]
33. Omega-3 polyunsaturated fatty acid biomarkers and risk of type 2 diabetes, cardiovascular disease, cancer, and mortality.
Jiang H; Wang L; Wang D; Yan N; Li C; Wu M; Wang F; Mi B; Chen F; Jia W; Liu X; Lv J; Liu Y; Lin J; Ma L
Clin Nutr; 2022 Aug; 41(8):1798-1807. PubMed ID: 35830775
[TBL] [Abstract][Full Text] [Related]
34. Aspirin and omega-3 polyunsaturated fatty acid use and their interaction in cardiovascular diseases and colorectal adenomas.
Wang IE; Yi S; Block RC; Mousa SA
Nutr Res Rev; 2022 Dec; 35(2):295-307. PubMed ID: 34253265
[TBL] [Abstract][Full Text] [Related]
35. Changes in eicosapentaenoic acid and docosahexaenoic acid and risk of cardiovascular events and atrial fibrillation: A secondary analysis of the OMEMI trial.
Myhre PL; Kalstad AA; Tveit SH; Laake K; Schmidt EB; Smith P; Nilsen DWT; Tveit A; Solheim S; Arnesen H; Seljeflot I
J Intern Med; 2022 May; 291(5):637-647. PubMed ID: 34982486
[TBL] [Abstract][Full Text] [Related]
36. Potential applications of fish oils rich in omega-3 polyunsaturated fatty acids in the management of gastrointestinal cancer.
Eltweri AM; Thomas AL; Metcalfe M; Calder PC; Dennison AR; Bowrey DJ
Clin Nutr; 2017 Feb; 36(1):65-78. PubMed ID: 26833289
[TBL] [Abstract][Full Text] [Related]
37. Efficacy of omega-3 PUFAs in depression: A meta-analysis.
Liao Y; Xie B; Zhang H; He Q; Guo L; Subramanieapillai M; Fan B; Lu C; McIntyre RS
Transl Psychiatry; 2019 Aug; 9(1):190. PubMed ID: 31383846
[TBL] [Abstract][Full Text] [Related]
38. n-3 PUFAs and cardiovascular disease prevention.
Manerba A; Vizzardi E; Metra M; Dei Cas L
Future Cardiol; 2010 May; 6(3):343-50. PubMed ID: 20462340
[TBL] [Abstract][Full Text] [Related]
39. Omega-3 fatty acids and cardiovascular prevention: is the jury still out?
Hamilton-Craig C; Kostner K; Colquhoun D; Nicholls SJ
Intern Med J; 2023 Dec; 53(12):2330-2335. PubMed ID: 38105550
[TBL] [Abstract][Full Text] [Related]
40. Omega-3 polyunsaturated fatty acids inhibit the increase in cytokines and chemotactic factors induced in vitro by lymph fluid from an intestinal ischemia-reperfusion injury model.
Zhang R; He GZ; Wang YK; Zhou KG; Ma EL
Nutrition; 2015 Mar; 31(3):508-14. PubMed ID: 25701342
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
